EFAI (6841.TWO) monthly revenue, September 2026
EFAI reported revenue of NT$0.04bn for September 2026, down 7.5% from the previous month and up 65.3% from a year earlier. Year-to-date revenue was NT$0.27bn, up 18.2% year on year. It ranked 20 of 159 companies in the Biotechnology and Medical Care industry by year-on-year growth.
| Month | Revenue NT$bn | MoM % | YoY % |
|---|---|---|---|
| September 2026 | 0.04 | -7.5 | 65.3 |